🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,196 results for “GE” Clear

  1. Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the safety, tolerability and pharmacokinetics of topical ocular administration of DS101 in healthy subjects.

    The George Institute

    Diabetic retinopathy.

    phase 1 other active

    1 trial

  2. Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the safety, tolerability and pharmacokinetics of topical ocular administration of DS101 in healthy subjects.

    The George Institute

    Diabetic retinopathy.

    phase 1 other active

    1 trial

  3. Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.

    The George Institute

    graft-versus-host disease

    phase 1 other active

    1 trial

  4. Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.

    The George Institute

    graft-versus-host disease

    phase 1 other active

    1 trial

  5. Phase Ib Dose Finding Study of [177Lu]Lu-NeoB in Combination with RT and TMZ in Newly Diagnosed Glioblastoma and as a Single Agent in Recurrent Glioblastoma

    Novartis Pharmaceuticals

    Glioblastoma

    phase 1 other active

    1 trial

  6. Placebo

    Regeneron UK Limited

    Atopic Dermatitis

    phase 1 small molecule completed

    3 trials

  7. Placebo

    Eloxx Pharmaceuticals

    Genetic Disease

    phase 1 small molecule completed

    1 trial

  8. Placebo gelatin pill

    Universal Integrated

    Vaginosis, Bacterial

    phase 1 small molecule completed

    1 trial

  9. Placebo oral capsule

    Biogen

    Healthy

    phase 1 small molecule completed

    1 trial

  10. Ponatinib

    Takeda

    Chronic Myelogenous Leukemia

    phase 1 small molecule completed

    1 trial

  11. Pozelimab

    Regeneron UK Limited

    Geographic Atrophy (GA)

    phase 1 small molecule active

    1 trial

  12. Pozelimab

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  13. Pozelimab

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  14. Pozelimab/Cemdisiran

    Regeneron UK Limited

    Sporadic Inclusion Body Myositis (sIBM)

    phase 1 other active

    1 trial

  15. Prizloncabtagene Autoleucel

    The First People's Hospital of Lianyungang

    Non-Hodgkin's B-cell Lymphoma

    phase 1 mab active

    1 trial

  16. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 1 small molecule completed

    1 trial

  17. Progesterone vaginal ring,

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  18. Protexia

    United Therapeutics Europe Ltd

    Intervention for Nerve Agent Exposure

    phase 1 mab completed

    1 trial

  19. Provision of extra (care coordination and management) services

    United Therapeutics Europe Ltd

    Hospitalization

    phase 1 other completed

    1 trial

  20. Provox Xtra HME

    ATOSSA THERAPEUTICS, INC.

    Total Laryngectomy

    phase 1 other completed

    1 trial

  21. PvP001 100 mg

    Takeda

    Digestive System Disease

    phase 1 small molecule completed

    1 trial

  22. REGEND001

    The First People's Hospital of Lianyungang

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  23. REGN1033

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. REGN1033

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources